Ningbo Bohui Chemical Technology Co.,Ltd

SZSE:300839 Stock Report

Market Cap: CN¥1.8b

Ningbo Bohui Chemical TechnologyLtd Past Earnings Performance

Past criteria checks 0/6

Ningbo Bohui Chemical TechnologyLtd's earnings have been declining at an average annual rate of -45.9%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 28.7% per year.

Key information

-45.9%

Earnings growth rate

-47.5%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate28.7%
Return on equity-79.8%
Net Margin-20.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Ningbo Bohui Chemical Technology Co.,Ltd (SZSE:300839) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Oct 08
Ningbo Bohui Chemical Technology Co.,Ltd (SZSE:300839) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Even With A 37% Surge, Cautious Investors Are Not Rewarding Ningbo Bohui Chemical Technology Co.,Ltd's (SZSE:300839) Performance Completely

Aug 09
Even With A 37% Surge, Cautious Investors Are Not Rewarding Ningbo Bohui Chemical Technology Co.,Ltd's (SZSE:300839) Performance Completely

Ningbo Bohui Chemical Technology Co.,Ltd (SZSE:300839) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 14
Ningbo Bohui Chemical Technology Co.,Ltd (SZSE:300839) Might Not Be As Mispriced As It Looks After Plunging 30%

Ningbo Bohui Chemical Technology Co.,Ltd's (SZSE:300839) Shares Bounce 26% But Its Business Still Trails The Market

Mar 07
Ningbo Bohui Chemical Technology Co.,Ltd's (SZSE:300839) Shares Bounce 26% But Its Business Still Trails The Market

Revenue & Expenses Breakdown

How Ningbo Bohui Chemical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300839 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,385-4965955
30 Jun 243,025-4196560
31 Mar 243,155-3566363
31 Dec 232,778-2036063
30 Sep 232,7382006574
30 Jun 232,9352205684
31 Mar 232,7511854675
01 Jan 232,9651524875
30 Sep 222,7691223460
30 Jun 222,227673542
31 Mar 221,995423636
31 Dec 211,714303231
30 Sep 211,48353133
30 Jun 211,182203932
31 Mar 211,142473536
31 Dec 20972583434
30 Sep 201,1821054832
30 Jun 20879812424
31 Mar 20821752720
31 Dec 19827762322
30 Sep 19365321112
30 Jun 19665692023
31 Mar 19623792122
31 Dec 18582892120
30 Sep 185481002017
30 Jun 185151102014
31 Mar 18438972012
31 Dec 17362842111
30 Sep 1733175217
30 Jun 1730066234
31 Mar 1728268262
31 Dec 1626370220
30 Sep 1623367200
30 Jun 1620363210
31 Mar 1620555210
31 Dec 1520747180
30 Sep 1522542210
30 Jun 1524436220
31 Mar 1524532210
31 Dec 1424728190
31 Dec 131184130

Quality Earnings: 300839 is currently unprofitable.

Growing Profit Margin: 300839 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300839 is unprofitable, and losses have increased over the past 5 years at a rate of 45.9% per year.

Accelerating Growth: Unable to compare 300839's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300839 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).


Return on Equity

High ROE: 300839 has a negative Return on Equity (-79.83%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies